Ajayi A A, Lees K R, Reid J L
Eur J Clin Pharmacol. 1986;30(2):177-82. doi: 10.1007/BF00614298.
The effect of the angiotensin converting enzyme inhibitor, perindopril, on autonomic function was assessed in a double blind, placebo controlled, crossover study in 10 normotensive males. Eight milligram of perindopril given orally lowered blood pressure without a change in heart rate. Perindopril enhanced the vagally mediated heart rate variation with deep breathing. There was no impairment of the responses to either bicycle exercise at 175 W for 5 min or isometric handgrip. The pressor response to cold was not changed and the response to the Valsalva manoeuvre was unaltered. These results suggest that the absence of tachycardia after perindopril may be in part related, as has been reported with other converting enzyme inhibitors, to enhanced cardiac parasympathetic tone. Vagomimetic action may be a property of converting enzyme inhibitors in general.
在一项针对10名血压正常男性的双盲、安慰剂对照、交叉研究中,评估了血管紧张素转换酶抑制剂培哚普利对自主神经功能的影响。口服8毫克培哚普利可降低血压,但心率无变化。培哚普利增强了深呼吸时由迷走神经介导的心率变异性。对于175瓦持续5分钟的自行车运动或等长握力运动,其反应均未受损。对冷刺激的升压反应未改变,对瓦尔萨尔瓦动作的反应也未改变。这些结果表明,培哚普利后无心动过速现象可能部分与其他转换酶抑制剂的情况一样,与心脏副交感神经张力增强有关。拟迷走神经作用可能是一般转换酶抑制剂的特性。